Table 1.
Participant Characteristics and Clinical Laboratory Values
| Variable | ACE | Control | P value |
|---|---|---|---|
| N | 22 | 23 | – |
| ACE score | 4 ± 2 | 0 ± 0 | <0.001 |
| Sex (M/F) | 14/8 | 10/13 | 0.113 |
| Race (C/AA) | 9/13 | 11/12 | 0.291 |
| Age (yrs) | 34 ± 3 | 31 ± 5 | 0.135 |
| Height (cm) | 174 ± 9 | 164 ± 8 | 0.194 |
| Weight (kg) | 88 ± 17 | 79 ± 20 | 0.134 |
| BMI (kg/m2) | 29.5 ± 3.7 | 26.9 ± 4.5 | 0.186 |
| Waist/hip ratio | 0.9 ± 0.1 | 0.9 ± 0.1 | 0.321 |
| Heart rate (bpm) | 63 ± 17 | 59 ± 11 | 0.299 |
| SBP (mmHg) | 121 ± 9 | 112 ± 8 | 0.110 |
| DBP (mmHg) | 75 ± 6 | 72 ± 6 | 0.148 |
| MAP (mmHg) | 90 ± 6 | 85 ± 7 | 0.101 |
| TC (mg/dL) | 175 ± 23 | 162 ± 28 | 0.201 |
| HDL (mg/dL) | 51 ± 12 | 56 ± 18 | 0.201 |
| LDL (mg/dL) | 95 ± 29 | 84 ± 28 | 0.183 |
| TRIG (mg/dL) | 101 ± 29 | 82 ± 32 | 0.106 |
| TC/HDL ratio | 3.5 ± 0.9 | 3.0 ± 1.1 | 0.109 |
| GLU (mg/dL) | 90 ± 8 | 87 ± 8 | 0.106 |
| HbA1C (%) | 5.5 ± 0.3 | 5.4 ± 0.4 | 0.103 |
| Hb (g/dL) | 14.7 ± 1.6 | 14.1 ± 1.4 | 0.112 |
| Hct (%) | 44 ± 4 | 42 ± 4 | 0.791 |
| hs-CRP (mg/L) | 2.3 ± 1.5 | 1.7 ± 1.5 | 0.190 |
Values are mean ± standard deviation (S.D.). Boldfaced value indicates statistical significance. ACE: Adverse childhood event; M: male; F: female; C: Caucasian; AA.: African American; BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; MAP: mean arterial blood pressure; TC: total cholesterol; HDL: high density lipoproteins; LDL: low density lipoproteins; TRIG: triglycerides; GLU: glucose; HbA1c: hemoglobin A1c; Hb: hemoglobin; Hct: hematocrit; hs-CRP: high sensitivity C-reactive protein.